Ceftaroline Fosamil Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Ceftaroline fosamil is a novel broad-spectrum cephalosporin approved by the EMA in 2012 for the treatment of adults with complicated skin and soft-tissue infections (cSSTIs) and community-acquired pneumonia (CAP) [18].Ceftaroline Fosamil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceftaroline Fosamil Nitroso Impurity 1 CAS NO:NA chemically represented as (Z)-2-(2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetamido)-2-(5-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-3-nitroso-3,6-dihydro-2H-1,3-thiazin-2-yl)acetate . Synchemia is the leading manufacturing and exporter of Ceftaroline Fosamil Nitroso Impurity 1 . We supply Ceftaroline Fosamil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014823 |
| CAS No | NA |
| Mol.F. | C17H21N11O7 |
| Mol.Wt. | 491.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014824 |
| CAS No | NA |
| Mol.F. | C11H12BrN3O |
| Mol.Wt. | 272.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014825 |
| CAS No | NA |
| Mol.F. | C26H26N2O3 |
| Mol.Wt. | 414.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014826 |
| CAS No | NA |
| Mol.F. | C15H20N4O3S |
| Mol.Wt. | 336.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014827 |
| CAS No | NA |
| Mol.F. | C23H30N2O4 |
| Mol.Wt. | 398.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014828 |
| CAS No | NA |
| Mol.F. | C19H24N2O3 |
| Mol.Wt. | 328.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014829 |
| CAS No | NA |
| Mol.F. | C26H28N2O3 |
| Mol.Wt. | 416.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014830 |
| CAS No | NA |
| Mol.F. | C26H30N2O2 |
| Mol.Wt. | 402.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014831 |
| CAS No | NA |
| Mol.F. | C26H28N2O3 |
| Mol.Wt. | 416.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014832 |
| CAS No | NA |
| Mol.F. | C7H6ClN5O3 |
| Mol.Wt. | 243.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014833 |
| CAS No | NA |
| Mol.F. | C14H20N4O3S |
| Mol.Wt. | 324.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014834 |
| CAS No | NA |
| Mol.F. | C14H19N5O4S |
| Mol.Wt. | 353.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014835 |
| CAS No | NA |
| Mol.F. | C11H15N3O2 |
| Mol.Wt. | 221.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014836 |
| CAS No | NA |
| Mol.F. | C27H36N6O3S |
| Mol.Wt. | 524.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014837 |
| CAS No | 75051-59-1 |
| Mol.F. | C11H15N3O2 |
| Mol.Wt. | 221.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014838 |
| CAS No | NA |
| Mol.F. | C14H20N4O4S |
| Mol.Wt. | 340.4 |
| INV STATUS | CUSTOM SYNTHESIS |